Insider · CIK 0001559583
John W Smither
Files at GNLX (GENELUX Corp), NAMS (NewAmsterdam Pharma Co N.V.). First filing Sep 9, 2026, latest Sep 9, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NAMS: NewAmsterdam Pharma Co N.V.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | NAMSsell NewAmsterdam Pharma Co N.V. | $41k 1,600 shares | -15% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | NAMS NewAmsterdam Pharma Co N.V. | SOpen-market sale Ordinary Shares | -1,600 | $25.32 | $41k | 8,760 | 33 d ago |
| Aug 1, 2024 | GNLX GENELUX Corp | AGrant or award Stock Option Right to Buy)derivative | +50,469 | $0.00 | $0 | 50,469 | Dec 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.